Minnesota 2025 2025-2026 Regular Session

Minnesota Senate Bill SF205 Introduced / Bill

Filed 01/15/2025

                    1.1	A bill for an act​
1.2 relating to health; prohibiting prior authorization of antineoplastic cancer treatment;​
1.3 amending Minnesota Statutes 2024, section 62M.07, subdivision 2.​
1.4BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
1.5 Section 1. Minnesota Statutes 2024, section 62M.07, subdivision 2, is amended to read:​
1.6 Subd. 2.Prior authorization of certain services prohibited.No utilization review​
1.7organization, health plan company, or claims administrator may conduct or require prior​
1.8authorization of:​
1.9 (1) emergency confinement or an emergency service. The enrollee or the enrollee's​
1.10authorized representative may be required to notify the health plan company, claims​
1.11administrator, or utilization review organization as soon as reasonably possible after the​
1.12beginning of the emergency confinement or emergency service;​
1.13 (2) outpatient mental health treatment or outpatient substance use disorder treatment,​
1.14except for treatment which is a medication. Prior authorizations required for medications​
1.15used for outpatient mental health treatment or outpatient substance use disorder treatment​
1.16must be processed according to section 62M.05, subdivision 3b, for initial determinations,​
1.17and according to section 62M.06, subdivision 2, for appeals;​
1.18 (3) antineoplastic cancer treatment that is consistent with guidelines of the National​
1.19Comprehensive Cancer Network, except for including but not limited to treatment which​
1.20that is a medication. Prior authorizations required for medications used for antineoplastic​
1.21cancer treatment must be processed according to section 62M.05, subdivision 3b, for initial​
1.22determinations, and according to section 62M.06, subdivision 2, for appeals;​
1​Section 1.​
25-00578 as introduced​11/18/24 REVISOR SGS/NS​
SENATE​
STATE OF MINNESOTA​
S.F. No. 205​NINETY-FOURTH SESSION​
(SENATE AUTHORS: PORT, Mann, Maye Quade and Boldon)​
OFFICIAL STATUS​D-PG​DATE​
Introduction and first reading​01/16/2025​
Referred to Commerce and Consumer Protection​ 2.1 (4) services that currently have a rating of A or B from the United States Preventive​
2.2Services Task Force, immunizations recommended by the Advisory Committee on​
2.3Immunization Practices of the Centers for Disease Control and Prevention, or preventive​
2.4services and screenings provided to women as described in Code of Federal Regulations,​
2.5title 45, section 147.130;​
2.6 (5) pediatric hospice services provided by a hospice provider licensed under sections​
2.7144A.75 to 144A.755; and​
2.8 (6) treatment delivered through a neonatal abstinence program operated by pediatric​
2.9pain or palliative care subspecialists.​
2.10Clauses (2) to (6) are effective January 1, 2026, and apply to health benefit plans offered,​
2.11sold, issued, or renewed on or after that date.​
2.12 EFFECTIVE DATE.This section is effective January 1, 2027, and applies to health​
2.13benefit plans offered, sold, issued, or renewed on or after that date.​
2​Section 1.​
25-00578 as introduced​11/18/24 REVISOR SGS/NS​